Sumukh Vasisht Shankar

Oct 7, 2024 | medrxiv.org | Lovedeep Singh Dhingra |Arya Aminorroaya |Aline Pedroso Camargos |Sumukh Vasisht Shankar

Dr. Khera is an Associate Editor of JAMA. Dr. Khera and Mr. Sangha are the coinventors of U.S. Provisional Patent Application No. 63/346,610, "Articles and methods for format-independent detection of hidden cardiovascular disease from printed electrocardiographic images using deep learning" and are co-founders of Ensight-AI.

Aug 26, 2024 | medrxiv.org | Evangelos Oikonomou |Sumukh Vasisht Shankar |Andreas C. Coppi |Harlan M. Krumholz

R.K. is an Associate Editor of JAMA and receives research support, through Yale, from the Blavatnik Foundation, Bristol-Myers Squibb, Novo Nordisk, and BridgeBio. He is a coinventor of U.S. Provisional Patent Applications 63/177,117, 63/428,569, 63/346,610, 63/484,426, 63/508,315, 63/580,137, 63/606,203, 63/562,335, 18/813,882, and a co-founder of Ensight-AI, Inc and Evidence2Health, LLC.

May 8, 2024 | nature.com | Arya Aminorroaya |Lovedeep S Dhingra |Evangelos Oikonomou |Sumukh Vasisht Shankar

AbstractElevated lipoprotein (a) (Lp(a)) is associated with premature atherosclerotic cardiovascular disease. However, fewer than 0.5% of individuals undergo Lp(a) testing, limiting the evaluation and use of novel targeted therapeutics currently under development. Here we describe the development of a machine learning model for targeted screening for elevated Lp(a) (≥150 nmol l−1) in the UK Biobank (N = 456,815), the largest cohort with protocolized Lp(a) testing.

Mar 19, 2024 | medrxiv.org | Arya Aminorroaya |Lovedeep Singh Dhingra |Aline Pedroso Camargos |Sumukh Vasisht Shankar

Dr. Khera is an Associate Editor of JAMA. He receives support from the National Heart, Lung, and Blood Institute of the National Institutes of Health (under awards R01HL167858 and K23HL153775) and the Doris Duke Charitable Foundation (under award 2022060). He also receives research support, through Yale, from Bristol-Myers Squibb, Novo Nordisk, and BridgeBio.